despit
signific
advanc
understand
molecular
basi
hostpathogen
relationship
associ
immunolog
respons
sever
sepsi
remain
problem
worldwid
associ
multipl
organ
dysfunct
elev
mortal
annual
peopl
usa
die
septic
shock
sever
form
sepsi
therebi
repres
common
caus
death
intens
care
unit
icu
morbid
mortal
sever
sepsi
usual
ascrib
incorrect
delay
diagnosi
inadequ
antimicrobi
therapi
underli
ill
recent
hostspecif
immun
respons
shown
anoth
import
determin
outcom
infecti
diseas
geneticallydetermin
differ
immun
respons
might
explain
peopl
get
sick
die
encount
pathogen
wherea
other
stay
perfectli
healthi
aim
chapter
review
current
knowledg
regard
genet
variabl
associ
increas
suscept
sever
sepsi
emphasi
select
polymorph
associ
poor
outcom
extens
review
recent
publish
influenc
genet
factor
determin
suscept
resist
sever
infecti
diseas
long
suspect
numer
report
anim
model
ethnic
group
famili
case
twin
adopte
studi
definit
prove
import
genet
sever
infect
use
anim
model
mimic
human
sever
sepsi
import
elucid
molecular
mechan
sepsi
genet
factor
differenti
inbr
strain
epigenet
factor
elicit
variat
within
strain
regard
preval
genet
strain
differ
contribut
suscept
microbi
infect
well
recogn
rodent
model
essenti
mice
genet
well
defin
may
easili
geneticallymodifi
use
geneticallyengin
strain
knockout
demonstr
physiolog
import
suspect
gene
interest
studi
mice
lie
fact
nearli
murin
gene
involv
respons
sepsi
human
homolog
analysi
suscept
certain
infecti
diseas
mice
led
map
identif
candid
gene
human
studi
henc
group
shown
tolllik
receptor
knockout
mice
respond
staphylococcu
aureu
infect
bacteri
challeng
mice
decreas
product
cytokin
increas
concentr
bacteria
blood
kidney
higher
mortal
rate
wildtyp
mice
similarli
infect
mycobacterium
tuberculosi
knockout
mice
defici
bacteri
clearanc
develop
chronic
pneumonia
interestingli
similar
suscept
aureu
infect
tuberculosi
report
human
popul
carri
polymorph
identif
effect
human
state
valid
use
murin
knockout
model
identifi
key
pathway
control
predisposit
infect
studi
twin
also
provid
argument
genet
program
suscept
infect
homozyg
twin
genom
compar
heterozyg
twin
genet
differ
studi
clearli
demonstr
case
infect
first
twin
risk
second
one
infect
pathogen
higher
homozyg
pair
versu
heterozyg
pair
estim
genet
predisposit
independ
environment
effect
obtain
also
adopte
studi
sorensen
et
al
report
larg
studi
etiolog
prematur
death
famili
children
adopt
earli
life
adopte
biolog
parent
die
age
infecti
diseas
increas
rel
risk
die
infect
contrast
death
adopt
parent
infecti
caus
signific
effect
adopte
risk
death
clearli
indic
host
genet
factor
major
determin
suscept
infecti
diseas
genet
predisposit
sever
sepsi
may
either
monogen
complex
multifactori
disord
monogen
diseas
mutat
singl
gene
necessari
suffici
produc
clinic
phenotyp
rare
major
genet
defect
immun
system
identifi
commonli
associ
unusu
recurr
bacteri
infect
detect
childhood
recent
genet
defect
shown
respons
lethal
tuberculosi
sever
bacteri
infect
thu
predisposit
rare
atyp
mycobacteria
chelonia
fortuitum
avi
dissemin
bacil
calmetteguerin
bcg
vaccin
infect
describ
children
lack
either
chain
interferongamma
receptor
interleukin
il
receptor
singl
gene
defect
provid
valuabl
insight
molecular
cellular
basi
host
immun
specif
pathogen
even
singl
mutat
locu
may
gener
larg
spectrum
phenotyp
term
diseas
sever
cystic
fibrosi
classic
exampl
monogen
trait
identifi
mutat
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
mutat
associ
develop
clinic
sign
cystic
fibrosi
larg
variat
sever
phenotyp
exist
genotyp
inde
modifi
effect
gene
may
result
mark
variat
symptom
patient
diseas
common
diseas
diabet
asthma
hypertens
thought
result
combin
divers
genet
environment
factor
genet
predisposit
sever
sepsi
also
consid
nonmendelian
diseas
complex
diseas
differ
dramat
ill
associ
singlegen
defect
complex
common
diseas
result
fact
penetr
frequenc
genotyp
give
rise
diseas
highli
variabl
henc
even
ident
twin
multifactori
diseas
second
twin
may
develop
trait
addit
definit
necessari
understand
molecular
basi
genet
predisposit
sever
sepsi
polymorph
region
genom
vari
individu
member
popul
present
popul
singl
nucleotid
polymorph
snp
polymorph
caus
chang
singl
nucleotid
differ
may
invers
g
c
transit
gc
invers
insert
delet
one
base
genet
variat
individu
human
believ
due
snp
variant
import
duplic
gene
repeat
dna
sequenc
human
carri
two
set
chromosom
one
parent
equival
gene
two
set
might
differ
snp
polymorph
allel
one
two
form
particular
gene
particular
combin
allel
sequenc
variat
close
link
chromosom
name
haplotyp
complex
diseas
sepsi
characterist
caus
interact
genet
environment
determin
identifi
gene
might
confer
suscept
resist
sever
sepsi
differ
approach
may
use
depend
histor
evid
eas
recruit
studi
popul
cost
genotyp
current
studi
field
sepsi
associ
genet
studi
involv
binari
diseas
trait
develop
septic
shock
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
mof
mortal
function
gene
two
allel
requir
adequ
number
unrel
individu
type
gene
interest
class
trait
fulfil
recommend
criteria
publish
guidelin
valid
genet
associ
studi
reli
basic
rule
studi
popul
homogen
allel
frequenc
frequencydepend
measur
like
linkag
disequilibrium
estim
accur
properli
identifi
sampl
popul
control
group
hardyweinberg
equilibrium
sampl
design
crucial
adequ
studi
size
studi
power
also
necessari
exclud
fals
conclus
definit
phenotyp
key
issu
design
genet
studi
whose
goal
detect
gene
involv
cours
diseas
exampl
select
sever
ill
septic
patient
without
signific
comorbid
may
help
identifi
candid
gene
respons
septic
shock
inclus
patient
sever
comorbid
receiv
treatment
contribut
mortal
inappropri
antibiot
lead
fals
neg
studi
despit
limit
associ
studi
design
simpl
provid
high
power
detect
common
genet
variant
confer
suscept
sepsi
howev
interpret
result
complex
tabl
antimicrobi
host
defens
complex
process
reli
innat
adapt
compon
gener
larg
repertoir
antigenrecognit
receptor
immun
memori
hallmark
acquir
immun
depend
presenc
effici
innat
immun
henc
innat
immun
repres
firstlin
host
defens
necessari
limit
infect
earli
hour
pathogen
invas
control
adapt
immun
respons
earli
protect
microorgan
involv
three
mechan
recognit
pathogen
phagocytosi
elimin
invad
microorgan
develop
inflammatori
respons
necessari
resolut
infect
step
immun
reaction
may
affect
gene
polymorph
individu
compon
immun
system
lead
suscept
resist
infect
associ
organ
failur
andor
risk
death
gene
polymorph
alter
pathogen
recognit
tabl
throughout
evolut
innat
immun
develop
effici
system
recogn
invari
molecular
constitu
infecti
agent
call
pathogenassoci
molecular
pattern
pamp
system
detect
current
refer
pattern
recognit
receptor
prr
divid
three
class
solubl
receptor
mannos
bind
lectin
mbl
compon
complement
system
endocyt
receptor
receptor
scaveng
receptor
includ
marco
dcsign
signal
receptor
tlr
nucleotidebind
oligomer
domain
nod
receptor
almost
receptor
function
polymorph
associ
increas
suscept
sever
infect
primarili
decreas
clearanc
pathogen
howev
mbl
variant
potenti
associ
sever
mortal
septic
shock
mbl
member
collectin
famili
protein
calciumdepend
plasma
lectin
bind
sugar
possibl
endotoxin
microbi
surfac
activ
complement
act
socal
anteantibodi
mbl
also
directli
act
opsonin
bind
specif
receptor
express
cell
surfac
variou
cell
type
includ
monocyt
therebi
potenti
tlr
respons
thu
mbl
clearli
appear
pluripot
molecul
innat
immun
system
maxim
efficaci
protein
innat
immun
system
present
physiolog
signific
level
concentr
mbl
human
plasma
genet
determin
profoundli
reduc
either
structur
gene
mutat
promot
gene
polymorph
three
differ
allel
result
structur
variant
protein
identifi
codon
exon
mbl
gene
structur
variant
within
mbl
gene
common
frequenc
rang
reduc
complement
activ
independ
mbl
plasma
level
wherea
mbl
defici
explain
three
mutat
structur
gene
mutat
explain
mbl
serum
level
vari
wide
individu
genet
variat
also
detect
promot
region
mbl
gene
variat
report
control
plasma
level
structur
normal
mbl
particular
g
c
invers
posit
promot
region
associ
vari
express
level
mbl
furthermor
snp
alway
link
structur
variant
popul
creat
relev
haplotyp
exampl
median
serum
concentr
mbl
caucasian
found
ngml
wildtyp
genotyp
ngml
patient
heterozyg
codon
mutat
ngml
patient
homozyg
codon
mutat
larg
number
studi
attempt
defin
role
mbl
predispos
sever
infect
hibberd
et
al
report
larg
cohort
patient
meningococc
diseas
admit
pediatr
icu
second
cohort
children
surviv
meningococc
diseas
uk
studi
show
clear
associ
mbl
polymorph
suscept
meningococc
diseas
odd
ratio
homozyg
patient
hospit
studi
nation
studi
heterozyg
patient
also
increas
risk
meningococc
infect
lesser
degre
sinc
rang
hospit
studi
nation
studi
use
popul
attribut
fraction
assess
possibl
calcul
gene
variant
could
account
mani
third
meningococc
diseas
case
similarli
uk
adult
patient
homozyg
mbl
structur
variant
repres
northern
european
north
american
substanti
increas
risk
develop
invas
pneumococc
diseas
furthermor
prospect
monitor
critic
ill
patient
system
inflammatori
respons
syndrom
sir
presenc
mbl
variant
allel
associ
develop
sepsi
sever
sepsi
septic
shock
increas
risk
fatal
outcom
observ
patient
carri
variant
allel
data
show
genet
variant
contribut
inadequ
mbl
level
play
import
role
suscept
critic
ill
patient
develop
progress
sever
sepsi
confer
substanti
risk
fatal
outcom
antibodi
antibodi
receptor
complement
essenti
compon
defens
invas
encapsul
bacteria
pneumonia
haemophilu
influenza
neisseria
meningitidi
receptor
locat
phagocyt
cell
surfac
bind
fc
region
igg
mediat
bind
phagocytosi
destruct
bacteria
opson
igg
certain
genet
determin
variat
igg
receptor
neutrophil
well
monocyt
macrophag
associ
reduc
bind
antibodi
increas
risk
bacteremia
mening
studi
surviv
meningococc
diseas
patient
firstdegre
rel
patient
meningococc
diseas
healthi
control
combin
low
affin
polymorph
present
significantli
often
rel
patient
healthi
control
group
moreov
distribut
differ
patient
present
sepsi
present
mening
lipopolysaccharid
lp
recognit
cell
surfac
achiev
cooper
sever
protein
compon
includ
lpsbind
protein
lbp
lead
activ
nuclear
transcript
factor
nuclear
factorkappa
b
modul
cytokin
express
result
initi
hostmicrobi
interact
import
pathophysiolog
sepsi
report
polymorph
site
associ
alter
function
lp
receptor
complex
suscept
sever
sepsi
arbour
et
al
identifi
two
polymorph
gene
associ
hyporesponsiv
inhal
lp
human
lorenz
colleagu
studi
associ
two
mutat
outcom
patient
septic
shock
first
author
genotyp
patient
septic
shock
healthi
control
found
allel
present
exclus
patient
septic
shock
also
patient
comut
higher
preval
gramneg
infect
studi
confirm
result
shown
variant
associ
mortal
sir
interestingli
two
frequent
snp
show
associ
suscept
sever
meningococc
diseas
although
rare
mutat
implic
meningococc
suscept
despit
report
central
role
play
develop
gramneg
sepsi
addit
control
studi
increas
number
patient
requir
determin
whether
snp
associ
risk
sever
gramneg
sepsi
gene
contain
promot
polymorph
report
modul
densiti
express
membran
monocyt
circul
level
solubl
polymorph
report
associ
suscept
septic
shock
mortal
rate
condit
howev
evid
associ
found
trauma
patient
sever
sepsi
secondari
complic
mention
dispar
result
studi
may
due
studi
differ
includ
number
patient
analyz
type
patient
includ
trauma
pneumonia
surgeri
heterogen
patient
popul
ethnic
comorbid
inflammatori
reaction
essenti
compon
host
defens
mechan
inflamm
tightli
regul
mediat
initi
maintain
inflammatori
process
well
other
requir
resolut
cytokin
key
protein
regul
inflamm
small
protein
molecular
weight
rang
kda
primarili
involv
host
respons
infect
inflamm
cytokin
initi
orchestr
immun
reaction
local
andor
system
intercellular
regulatori
factor
within
minut
infecti
challeng
proinflammatori
cytokin
tumor
necrosi
factor
tnf
secret
lead
strong
activ
monocyt
chemokinerecruit
polymorphonuclear
cell
endotheli
cell
initi
proinflammatori
state
follow
releas
antiinflammatori
cytokin
inhibitori
protein
receptor
antagonist
abl
suppress
express
action
proinflammatori
cytokin
chemokin
adhes
molecul
proinflammatori
antiinflammatori
cytokin
coexist
infect
site
bloodstream
markedli
increas
amount
rel
concentr
correl
sever
outcom
septic
shock
human
cytokin
gene
polymorph
increas
evid
host
cytokin
product
genet
determin
sinc
cytokin
express
spontan
synthes
de
novo
respons
pathogen
function
promot
variant
gene
dramat
consequ
henc
genet
variabl
cytokin
underli
complex
interindividu
differ
immun
respons
microbi
invas
proinflammatori
cytokin
central
role
mani
inflammatori
diseas
includ
sever
sepsi
septic
shock
tnf
may
produc
mani
differ
cell
type
one
first
mediat
appear
respons
divers
rang
infecti
stimuli
secret
elicit
wide
spectrum
immun
inflammatori
respons
respons
fever
shock
tissu
injuri
induc
releas
addit
inflammatori
mediat
includ
cytokin
nitric
oxid
free
oxygen
radic
upregul
adhes
molecul
express
neutral
tnf
product
antitnf
antibodi
tnfknockout
mice
associ
increas
mortal
sever
model
infect
demonstr
tnf
critic
mediat
host
defens
infect
howev
tnf
may
caus
sever
patholog
produc
excess
vivo
inject
tnf
produc
clinic
manifest
mimick
observ
inject
bacteria
hemodynam
disturb
mortal
shown
correl
tnf
plasma
level
henc
excess
product
tnf
may
associ
tissu
injuri
shock
death
due
imbal
proinflammatori
antiinflammatori
cytokin
given
tnf
role
central
element
host
defens
respons
product
tightli
regul
preserv
cellular
homeostasi
interestingli
mark
interindividu
variabl
tnf
product
respons
differ
stimuli
report
healthi
subject
sinc
tnf
respons
infect
partli
regul
transcript
level
tnf
promot
polymorph
subject
intens
research
probabl
extens
studi
cytokin
involv
sepsi
pathophysiolog
public
two
polymorph
locu
link
variabl
tnf
product
first
polymorph
consist
g
call
call
base
pair
upstream
transcript
start
tnfa
associ
higher
secret
second
polymorph
locat
within
tnfb
gene
still
affect
synthesi
identifi
pociot
et
al
report
biallel
restrict
enzym
fragment
length
polymorph
rflp
tnf
gene
locu
associ
increas
product
site
map
first
intron
lt
gene
tnfb
posit
allow
definit
two
allel
latter
possess
rflp
seem
associ
increas
plasma
concentr
precis
mechan
underli
result
remain
unclear
polymorph
may
directli
relat
tnf
product
rather
serv
major
histocompat
complex
mhc
marker
locat
class
iii
region
mhc
signific
linkag
disequilibrium
two
tnf
snp
report
almost
individu
homozyg
high
tnf
produc
also
homozyg
low
tnf
produc
ad
complex
final
schema
tnf
product
polymorph
associ
greater
sever
wors
outcom
varieti
infecti
diseas
exampl
describ
independ
risk
factor
cerebr
malaria
larg
casecontrol
studi
african
popul
homozygos
allel
associ
rel
risk
death
sever
neurolog
sequela
due
cerebr
malaria
strong
associ
also
report
tnf
polymorph
mucocutan
leishmaniasi
scar
trachoma
lepromat
leprosi
nephropathia
epidemica
death
meningococc
diseas
sever
meliodosi
communityacquir
pneumonia
septic
shock
septic
shock
allel
increas
risk
death
fold
even
control
age
sever
ill
also
clearli
associ
increas
mortal
sepsi
neonat
ventil
low
birth
weight
infant
howev
studi
fail
demonstr
associ
either
mortal
discord
may
aris
least
part
methodolog
problem
incorrect
genotyp
assign
differ
studi
popul
inclus
exclus
criteria
sepsi
induc
initi
proinflammatori
respons
follow
import
releas
antiinflammatori
cytokin
respons
downregul
humor
cellular
immun
call
immunoparalysi
compensatori
antiinflammatori
respons
syndrom
car
genet
polymorph
respons
uncontrol
intens
car
may
dramat
consequ
outcom
sepsi
overwhelm
inflammatori
respons
express
secret
varieti
cell
type
includ
b
cell
monocytesmacrophag
epitheli
cell
usual
activ
stimulu
infect
suppress
function
macrophag
downregul
cytokin
indirectli
inhibit
activ
b
cell
high
product
also
inhibit
express
delay
clearanc
intracellular
pathogen
chlamydia
potent
antiinflammatori
effect
indic
cytokin
might
play
crucial
role
resolut
pathogenesi
sever
sepsi
septic
shock
concentr
correl
sever
inflammatori
respons
assess
apach
score
mof
death
risk
fatal
outcom
meningococc
diseas
increas
famili
high
product
although
genet
nongenet
factor
contribut
product
twin
studi
suggest
genet
could
account
variabl
product
human
gene
demonstr
sever
polymorph
result
interindividu
differ
cytokin
product
within
proxim
promot
two
carepeat
microsatellit
three
snp
ga
ct
ca
upstream
transcript
start
site
report
snp
distal
promot
identifi
recent
either
highor
low
product
phenotyp
therebi
creat
eight
distal
promot
haplotyp
vitro
polymorph
associ
high
product
lymphocyt
within
mandika
ethnic
group
homozyg
genotyp
significantli
common
among
trachoma
patient
control
odd
ratio
confid
interv
p
contrast
allel
appear
common
person
mildli
symptomat
asymptomat
epsteinbarr
viru
ebv
diseas
patient
ebv
infect
requir
hospit
find
suggest
high
produc
partial
protect
sever
ebv
infect
show
clearli
chang
level
given
cytokin
exert
effect
infecti
agent
may
explain
result
genet
associ
studi
polymorph
sepsi
contradictori
gg
genotyp
link
greater
express
associ
higher
sever
score
wors
outcom
patient
communityacquir
pneumonia
similarli
anoth
polymorph
allel
associ
low
level
associ
death
patient
sepsi
critic
ill
patient
without
sepsi
studi
although
allel
frequenc
significantli
differ
case
control
admiss
icu
associ
observ
allel
risk
death
sepsi
recent
new
haplotyp
associ
increas
mortal
organ
dysfunct
critic
ill
patient
sepsi
secondari
pulmonari
sourc
infect
similarli
ill
patient
extrapulmonari
sepsi
overal
data
suggest
role
genet
variat
gene
death
due
sever
sepsi
remain
inconsist
inflammatori
respons
observ
sever
sepsi
lead
strong
activ
coagul
fibrinolysi
howev
earli
increas
anticoagul
tissu
plasminogen
activ
rapidli
follow
sustain
elev
lead
prolong
antifibrinolyt
net
procoagul
state
activ
coagul
togeth
inhibit
fibrinolysi
respons
develop
fibrin
deposit
microthrombi
caus
extens
endotheli
damag
associ
mof
high
plasma
concentr
associ
advers
outcom
patient
sepsi
septic
shock
sever
polymorph
describ
within
human
pai
gene
locat
chromosom
includ
common
singlebasepair
polymorph
four
five
guanin
base
promot
region
gene
bp
upstream
transcript
start
site
allel
delet
polymorph
associ
higher
plasma
concentr
individu
homozyg
allel
higher
basal
induc
concentr
one
two
copi
allel
contain
addit
g
locat
promot
gene
insert
polymorph
addit
antifibrinolyt
properti
variant
also
seem
influenc
proinflammatori
cytokin
product
patient
higher
concentr
also
demonstr
significantli
higher
plasma
level
compar
genotyp
emont
three
studi
report
similar
result
indic
delet
promot
polymorph
influenc
prognosi
meningococc
diseas
sever
injur
patient
latter
studi
investig
relationship
outcom
sever
trauma
genotyp
found
injur
patient
genotyp
die
wherea
heterozyg
genotyp
patient
genotyp
surviv
sever
sepsi
complex
multifactori
polygen
disord
thought
result
interact
individu
genet
makeup
comorbid
diabet
mellitu
obes
cardiac
failur
environment
factor
invas
microorgan
respons
infect
recent
year
sever
studi
correl
genet
variat
risk
outcom
sever
sepsi
howev
result
studi
inconsist
enabl
use
conclus
drawn
inconsist
attribut
heterogen
select
patient
method
use
select
case
control
studi
size
genet
racial
makeup
popul
studi
variabl
microorgan
caus
infect
polymorph
report
real
multigen
scope
sever
sepsi
emerg
polymorph
present
individu
increasingli
complex
clinic
implic
develop
technolog
allow
highthroughput
fast
lowcost
genotyp
lead
greater
insight
host
suscept
level
individu
patient
genet
marker
like
biolog
marker
wide
rang
valu
overlap
peopl
without
diseas
rather
either
present
absent
howev
interact
environment
effect
molecular
mechan
influenc
outcom
sepsi
remain
poorli
understood
inherit
predisposit
sepsi
may
remain
clinic
silent
addit
environment
factor
occur
largescal
associ
studi
examin
mani
polymorph
simultan
requir
allow
reliabl
predict
made
concern
risk
incur
genet
factor
sever
infect
genet
screen
evalu
individu
risk
factor
infecti
diseas
becom
avail
insight
molecular
interact
pathogen
host
reveal
novel
molecular
target
drug
vaccin
increas
understand
molecular
medicin
shift
clinic
practic
empir
treatment
therapi
base
specif
cellular
mechan
infecti
diseas
approach
alreadi
use
oncolog
genet
test
clearli
identifi
person
high
risk
allow
target
intervent
spare
person
econom
cost
unnecessari
intervent
carri
relev
mutat
detect
genet
differ
affect
drug
respons
commonli
refer
pharmacogenom
may
also
result
classif
diseas
consequ
develop
person
therapi
anoth
import
consequ
develop
genom
begin
incorpor
genet
marker
sever
score
design
clinic
trial
diagnosi
lack
suffici
power
often
result
treatment
failur
factor
genet
characterist
host
polymorph
gene
regul
drug
bioavail
gene
regul
product
target
also
contribut
heterogen
respons
therapi
group
patient
genet
screen
improv
understand
hostpathogen
interact
allow
select
best
treatment
option
given
patient
last
least
import
point
consid
concern
ethic
implic
research
human
genom
human
genom
project
launch
parallel
program
name
elsi
ethic
legal
social
implic
establish
identifi
variou
consequ
genet
inform
avail
among
goal
elsi
includ
practic
ethic
issu
prepar
guidelin
clinician
enhanc
public
awar
ethic
issu
relat
human
genom
project
wherea
research
genet
predisposit
sever
sepsi
could
benefici
effect
also
carri
import
ethic
issu
use
presymptomat
screen
well
possibl
subsequ
social
discrimin
due
atrisk
polymorph
genet
data
use
predict
outcom
limit
treatment
rather
identif
highrisk
patient
help
us
look
new
prevent
therapeut
intervent
need
